Track topics on Twitter Track topics that are important to you
Caprice Bearden, a 63-year old ex-Director of Compliance for an Indiana-based Pharmakon, has been found guilty of introducing adulterated drugs into the market and obstructing the US FDA’s lawful fu...
Zürich - Merck-Aktienanalyse von Analyst Michael Leuchten von der UBS: Michael Leuchten, Analyst der UBS, nimmt in einer aktuellen Aktienanalyse die Coverage für die Aktie des Chemie- und Pharmakon....
We have published hundreds of AIM Pharmakon, Inc. news stories on BioPortfolio along with dozens of AIM Pharmakon, Inc. Clinical Trials and PubMed Articles about AIM Pharmakon, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AIM Pharmakon, Inc. Companies in our database. You can also find out about relevant AIM Pharmakon, Inc. Drugs and Medications on this site too.